The effects of early exercise on cardiovascular biomarkers in patients with congestive heart failure

The effects of early exercise on cardiovascular biomarkers in patients with congestive heart failure

Abstract Background Exercise training improves functional outcomes in chronic heart failure (HF), but the effects of early in‐hospital physical activity on cardiovascular biomarkers and prognosis in acute congestive heart failure (AHF) patients remain unclear. This study investigated the short‐term...

Full description

Saved in:

Bibliographic Details
Main Authors:	Yanxiang Sun, Xuansheng Huang, Bing Hu, Zidi Wu, Yanchun Zhang, Yong Yuan, Li Feng
Format:	Article
Language:	English
Published:	Wiley 2025-08-01
Series:	ESC Heart Failure
Subjects:	Biomarkers Exercise Heart failure hsTnT NT‐proBNP
Online Access:	https://doi.org/10.1002/ehf2.15317
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

NT-proBNP for Heart Failure Screening in Primary Care in an Eastern European Country: What We Know and Proposed Steps
by: Ioana Camelia Teleanu, et al.
Published: (2025-01-01)

Diagnostic Efficacy of Combined N-Terminal Pro-Brain Natriuretic Peptide (NT-proBNP) and Cardiac Troponin I (cTnI) Testing in Myocardial Injury of Children with Mycoplasma Pneumoniae Pneumonia
by: Yang M, et al.
Published: (2025-06-01)

Serum NT-ProBNP/Chloride Ratio Predicts Adverse Cardiovascular Outcomes in Patients with Acute Heart Failure
by: Victor José Leal-Alcántara, et al.
Published: (2025-06-01)

Value of circulating N-terminal pro-brain natriuretic peptide for prognosis of cardiovascular events in patients with non-Hodgkin lymphoma in remission
by: B. B. Samura
Published: (2015-12-01)

Elevation of Cardiac Biomarkers in COVID-19 As a Major Determinant for Mortality: A Systematic Review
by: Tracy Anabella Hermansyah, et al.
Published: (2022-01-01)

Circulative biomarkers as predictors of cardiovascular events in patients after treatment of Hodgkin lymphoma
by: B. B. Samura
Published: (2017-12-01)

N- terminal pro brain natriuratic peptide (nt-probnp) in apparently healthy subjects compared to metabolic syndrome subjects
by: Zaidan Azeez Hasan, et al.
Published: (2022-06-01)

Growth differentiation factor‐15 and N‐terminal pro‐BNP in acute heart failure with preserved ejection fraction
by: Yoichiro Otaki, et al.
Published: (2025-04-01)

Use of a Silicon Microneedle Chip-Based Device for the Extraction and Subsequent Analysis of Dermal Interstitial Fluid in Heart Failure Patients
by: Markus Renlund, et al.
Published: (2025-04-01)

Frailty determinants in heart failure: Inflammatory markers, cognitive impairment and psychosocial interaction
by: Marta Wleklik, et al.
Published: (2025-06-01)

Effects of Acute Exercise Bouts on Cardiovascular Biomarkers in Runners with Exercise-Induced Hypertension
by: Young-Joo Kim, et al.
Published: (2025-06-01)

Predictive value of circulating N-terminal pro-brain natriuretic peptide in patients after treatment of Hodgkin lymphoma (a 3-year prospective study)
by: B. B. Samura
Published: (2017-12-01)

NT-proBNP changes predict outcomes in elderly type 2 myocardial infarction patients
by: Jinling Ma, et al.
Published: (2025-07-01)

THE LEVEL OF CARDIAC PEPTIDE NT-PROBNP INCREASES DURING PRE-ECLAMPSIA OF PREGNANT WOMEN
by: Н. Русой, et al.
Published: (2025-04-01)

Pulmonary hypertension and NT-proBNP dynamics during the course of adulticide treatment in dogs naturally infected by Dirofilaria immitis
by: Noelia Costa-Rodríguez, et al.
Published: (2025-07-01)

Construction and clinical visualization application of a predictive model for mortality risk in sepsis patients based on an improved machine learning model
by: Ting Chen, et al.
Published: (2025-05-01)

Association between NT‐proBNP changes and clinical outcomes in paediatric patients with heart failure: Insights from PANORAMA‐HF and PARADIGM‐HF
by: Robert Shaddy, et al.
Published: (2025-08-01)

Cardioprotective effects of CoQ10 in pediatric patients with lysosomal storage disorders
by: Yasmine Abuzaid, et al.
Published: (2025-05-01)

Clinical value of NT-proBNP, MPO, and NLR combined with echocardiography in prediction of malignant arrhythmia in elderly patients with valvular heart disease
by: Jianping Liu, et al.
Published: (2025-04-01)

Exploring heart failure prevalence and dimensions: A comprehensive NT‐proBNP study in high‐risk primary care patients
by: Ahmet Celik, et al.
Published: (2025-08-01)

Recommendations for the use of natriuretic peptides for early diagnosis of heart disease in patients with diabetes: A consensus report by SPEDM, SPC, NEDM-SPMI and APMGF
by: João Sérgio Neves, et al.
Published: (2025-01-01)

Biomarkers of hemodynamic status in patients with moderate and severe COVID-19
by: Yu. K. Shapovalov
Published: (2022-12-01)

Clinical value of combined detection of serum ferritin and N-terminal pro-brain natriuretic peptide in the assessment of Kawasaki disease in children over 1 year of age
by: Zhen-qing Liu, et al.
Published: (2025-07-01)

Does perioperative electroacupuncture reduce the incidence of atrial fibrillation after lung cancer surgery? A randomized, controlled, assessor-blinded clinical trial
by: Zheng-qing Zhou, et al.
Published: (2025-05-01)

Biochemical Markers of Cardiotoxicity of High-Dose Chemotherapy and Autologous Hematopoietic Stem Cell Transplantation in Patients with Malignant Lymphoproliferative Disorders
by: VO Sarzhevskii, et al.
Published: (2016-10-01)

Cardiac Performance by Echocardiography, Cardiovascular Biomarker, Kidney Function, and Venous Oxygen Saturation as Mortality Predictors of Septic Shock
by: Pudjo Rahasto, et al.
Published: (2019-05-01)

Troponin, NT-proBNP and postoperative atrial fibrillation in a prospective cohort undergoing coronary artery bypass surgery
by: Amelie H. Ohlrogge, et al.
Published: (2025-08-01)

Accuracy of Established Prognostic Staging Systems for Cardiac Transthyretin Amyloidosis in the Tafamidis Era
by: Maximilian Leo Müller, MD, et al.
Published: (2025-02-01)

BIOMARKERS OF MYOCARDIAL STRESS AND FIBROSIS FOR CLINICAL OUTCOMES ASSESSMENT IN POST MYOCARDIAL INFARCTION HEART FAILURE PATIENTS
by: N V Shilyaeva, et al.
Published: (2018-03-01)

Importance of NT-pro BNP in the Prevention of Heart Failure, Left Ventricular Systolic Dysfunction and Cardiovascular Events
by: Irina CUCIUREANU, et al.
Published: (2021-06-01)

Chronic obstructive pulmonary disease and chronic heart failure in elderly people: literature review
by: V. A. Gubkina, et al.
Published: (2016-06-01)

GALECTIN-3 AND NT-proBNP AS BIOMARKERS OF HEART FAILURE DECOMPENSATION
by: Yu. V. Dubolazova, et al.
Published: (2017-02-01)

Minimizing unnecessary proBNP blood tests: an evaluation of a pop-up form implementation in general practice
by: Morvarid Sophia Esmaeilzadeh, et al.
Published: (2025-01-01)

Characteristics of patients with chronic heart failure in different age groups
by: R. I. Jafarov, et al.
Published: (2023-05-01)

Investigating the diagnostic accuracy of vertebral heart score, vertebral left atrium score and thoracic width measurement in cats with suspected cardiac problems
by: B. Ozdil, et al.
Published: (2025-03-01)

Relationships between the activity of neurohormonal systems and intracardiac hemodynamics in patients with heart failure: focus on galectin-3
by: V. I. Podzolkov, et al.
Published: (2022-05-01)

Exploring the association of natriuretic peptides with QTc interval in hemodialysis patients
by: Yoshihiro Matsumoto, et al.
Published: (2025-12-01)

Level and correlations of soluble suppression of tumorigenicity 2 protein in heart failure and its relationship with clinical and paraclinical characteristics of patients
by: A. Ya. Kravchenko, et al.
Published: (2022-06-01)

Bedside ultrasound assessment of venous congestion by VExUS protocol in heart failure: clinical associations and prognostic value
by: Zh. D. Kobalava, et al.
Published: (2023-10-01)

Chronic Heart Failure in Early Rheumatoid Arthritis Patients Prior to Basic Antirheumatic Therapy
by: I. G. Kirillova, et al.
Published: (2020-03-01)